Jana Van Dycke studied Biomedical Sciences at the University of Leuven, Belgium. After graduating in 2015, she joined the group of Prof. Johan Neyts (University of Leuven, Belgium) as an FWO-fellow, under the supervision of Dr. Joana-Rocha Pereira. The research of Prof. Neyts focuses on the development of antiviral strategies and vaccines against a range of human viruses. Jana obtained her PhD in 2020 for her work on the establishment of a novel small animal model to study human noroviruses and the identification of small molecule inhibitors of norovirus replication.
Within GUTVIBRATIONS, Jana will be supervised by Dr. Joana Rocha-Pereira and Prof. Johan Neyts.
Jana is working at the Rega Institute (KU Leuven) in the department of virology and chemotherapy. She will, in collaboration with Amsterdam University Medical Centers (Amsterdam UMC), aim to develop and optimize the gut epithelial-immune cell co-culture model and to prove that this model can be used as an infection model. Upon establishment the model will be used to assess toxicity and anti-norovirus activity of small molecule inhibitors.
KU Leuven is the largest university in Belgium, ranking 45th in the Times Higher Education ranking (2020) of worldwide universities and 1st as European University in the Reuters Top 100 of the World’s most innovative institutions. KU Leuven employs ~9.000 researchers on its academic staff. KU Leuven Research & Development (LRD) is the technology transfer office (TTO) of the KU Leuven where a multidisciplinary team of experts’ guide researchers in their interaction with industry and society, and the valorisation of their research results (101 spin offs). The Rega Institute for Medical Research (KUL-REGA) host part of the Department of Microbiology, Immunology and Transplantation and the Medicinal Chemistry section of the Department of Pharmaceutical Sciences, having a long-standing expertise in antiviral drug discovery (Brivudine, Tenofovir).